Related Experiment Video
Updated: Sep 26, 2026

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
Published on: April 28, 2013
Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection
Alain Laplante1, Dingyi Liu, Michel Demeule
1Laboratory of Molecular Medicine, UQAM-Sainte-Justine Hospital, C.P. 8888, Succursale Centre-Ville Montreal, Quebec, H3C 3P8, Canada.
Abstract:
Changes in matrix metalloproteinase (MMP) activities would contribute to the accumulation of extracellular matrix during acute kidney allograft rejection. MMP-2 and MMP-9 and other gelatinolytic activities were examined in the rejected graft and the urine of a rat model of acute kidney rejection (orthotopic allotransplantation from a Buffalo donor to a Wistar-Furth recipient) by either zymography or fluorescence assay. MMP-2, membrane type 1 (MT1)-MMP, and tissue inhibitor of metalloproteinase (TIMP)-2 were also examined by immunodetection. The proMMP-2 activity and protein level increased in the graft during rejection when compared with normal Buffalo kidney, whereas activated MMP-2 decreased. TIMP-2 protein levels were markedly decreased and MT1-MMP proteolytic fragments (44-40 kDa) were undetectable. This suggests an altered MT1-MMP-dependent processing of proMMP-2 into active MMP-2 due to a diminished TIMP-2 level in acute kidney rejection. In the urine the overall gelatinolytic activity decreased considerably, although activity associated with an as yet unidentified 78-kDa protein appeared 6 days after transplantation.
Insights
Matrix metalloproteinase (MMP) activity changes contribute to kidney allograft rejection. Altered MMP-2 processing, linked to decreased TIMP-2, occurs during acute rejection, impacting extracellular matrix accumulation.
Area of Science:
- Nephrology
- Immunology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) play a role in extracellular matrix remodeling.
- Altered MMP activity is implicated in kidney allograft rejection and fibrosis.
- Understanding MMP involvement is crucial for managing rejection.
Purpose of the Study:
- To investigate the role of MMP-2, MMP-9, and their inhibitors in acute kidney allograft rejection.
- To analyze changes in gelatinolytic activity in rejected grafts and urine.
- To elucidate the processing of proMMP-2 in the context of TIMP-2 and MT1-MMP during rejection.
Main Methods:
- Zymography and fluorescence assays to assess gelatinolytic activity in rat kidney allografts and urine.
- Immunodetection to quantify MMP-2, MT1-MMP, and TIMP-2 protein levels.
- Orthotopic kidney allotransplantation model (Buffalo to Wistar-Furth rats).
Main Results:
- Increased proMMP-2 activity and protein levels in rejected grafts compared to controls.
- Decreased activated MMP-2 and significantly reduced TIMP-2 protein levels during rejection.
- Undetectable MT1-MMP proteolytic fragments and altered proMMP-2 processing.
- Reduced overall urinary gelatinolytic activity, with a novel 78-kDa protein activity emerging post-transplantation.
Conclusions:
- Diminished TIMP-2 levels in acute kidney rejection impair MT1-MMP-dependent processing of proMMP-2 to active MMP-2.
- These MMP alterations contribute to extracellular matrix accumulation in rejecting allografts.
- Urinary MMP profiles may serve as potential biomarkers for kidney transplant rejection.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Acute Kidney Injury II: Pathophysiology
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Kidney Transplant III: Nursing Management